Variant report
Variant | nsv10555 |
---|---|
Chromosome Location | chr4:118723143-118725551 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187153639 | chr4:118723153-118723154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571745991 | chr4:118723154-118723155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370058200 | chr4:118723156-118723157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11562874 | chr4:118723245-118723246 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs372879105 | chr4:118723342-118723343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35304940 | chr4:118723361-118723362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371371122 | chr4:118723375-118723376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376739662 | chr4:118723383-118723384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7670296 | chr4:118723426-118723427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556446026 | chr4:118723434-118723435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576327198 | chr4:118723455-118723456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4574479 | chr4:118723487-118723488 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs72909324 | chr4:118723502-118723503 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs17862103 | chr4:118723594-118723595 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs180789331 | chr4:118723634-118723635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184977690 | chr4:118723643-118723644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530417460 | chr4:118723657-118723658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189781861 | chr4:118723738-118723739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550161238 | chr4:118723800-118723801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552359341 | chr4:118723801-118723802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17862104 | chr4:118723865-118723866 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs537979407 | chr4:118723879-118723880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138229910 | chr4:118723943-118723944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374355864 | chr4:118724045-118724046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551778751 | chr4:118724059-118724060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143413588 | chr4:118724060-118724061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538821787 | chr4:118724074-118724075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547587075 | chr4:118724104-118724105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567378066 | chr4:118724123-118724124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536496454 | chr4:118724142-118724143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs17869847 | chr4:118724146-118724147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147147111 | chr4:118724162-118724163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17862105 | chr4:118724179-118724180 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs138392141 | chr4:118724181-118724182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538925320 | chr4:118724198-118724199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559176461 | chr4:118724240-118724241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571344078 | chr4:118724245-118724246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115176816 | chr4:118724270-118724271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533909486 | chr4:118724330-118724331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17866059 | chr4:118724333-118724334 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs372272326 | chr4:118724352-118724353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553632361 | chr4:118724373-118724374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149264493 | chr4:118724431-118724432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553793354 | chr4:118724463-118724464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542876260 | chr4:118724480-118724481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533834616 | chr4:118724504-118724505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562648763 | chr4:118724509-118724510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576274192 | chr4:118724517-118724518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573604198 | chr4:118724557-118724558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113470051 | chr4:118724579-118724580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:118720200-118723400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr4:118720800-118726000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:118721800-118723200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr4:118722400-118723200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:118722600-118723200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:118722600-118723200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr4:118722600-118723200 | Enhancers | Fetal Kidney | kidney |
8 | chr4:118722600-118723800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr4:118722800-118723800 | Weak transcription | Placenta Amnion | Placenta Amnion |
10 | chr4:118723200-118728000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr4:118723400-118723800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr4:118723800-118724000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:118723800-118724000 | Enhancers | Placenta Amnion | Placenta Amnion |
14 | chr4:118723800-118726000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
15 | chr4:118724000-118726400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |